E pluribus unum-: Understanding Our Diversity and Disparities in Lp(a) Screening
- PMID: 38938864
- PMCID: PMC11198614
- DOI: 10.1016/j.jacadv.2024.100939
E pluribus unum-: Understanding Our Diversity and Disparities in Lp(a) Screening
Keywords: Lp(a); atherosclerosis; ethnic; lipid; prevention; risk.
Conflict of interest statement
Dr Bhatia was partially supported by 10.13039/100000002NIH 1K08HL166962; and has received consulting fees from Kaneka Medical and Novartis Pharmaceuticals. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
Comment on
- doi: 10.1016/j.jacadv.2024.100940
References
-
- Zafrir B., Aker A., Saliba W. Lipoprotein(a) testing in clinical practice: real-life data from a large health-care provider. Eur J Prev Cardiol. 2022;29:e331–e333. - PubMed
-
- Stürzebecher P.E., Schorr J.J., Klebs S.H.G., et al. Trends and consequences of lipoprotein(a) testing: cross-sectional and longitudinal health insurance claims database analyses. Atherosclerosis. 2023;367:24–33. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous